Daunorubicin and cytarabine liposome (Intravenous)

Daunorubicin and cytarabine liposome (Intravenous)

Active Ingredients
daunorubicin and cytarabine liposome
Drug Classes
Antineoplastic combinations
logo
Scoring is done by our AI based assistant on the data from the FDA and other sources
Effectiveness
Safety
Addiction
Ease of Use
Contraindications

Daunorubicin and cytarabine liposome (Intravenous): Alternative Drugs By Action

8.1
Kisqali Femara Co-Pack (Oral)
7.5
Nivolumab and relatlimab
7.4
Opdualag
7.1
Inqovi
7.0
Lonsurf
6.9
Akeega
6.7
Trifluridine and tipiracil (Oral)
6.1
Nivolumab/
6.1
Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
6.1
Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
5.8
Decitabine and cedazuridine (Oral)
5.5
Cytarabine and daunorubicin (liposomal)
5.5
Niraparib and abiraterone (Oral)
5.5
Cedazuridine and decitabine
5.3
Abiraterone and niraparib
5.3
Tipiracil and trifluridine
5.2
Vyxeos (liposomal)
5.2
Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
4.8
Ribociclib and letrozole (Oral)
4.7
Letrozole and ribociclib
Browse Drugs by Alphabet